Issue 6/2023
Content (12 Articles)
Real-World Experience of Methotrexate in the Treatment of Skin Diseases: an Italian Delphi Consensus
Giovanni Damiani, Paolo Amerio, Federico Bardazzi, Carlo G. Carrera, Andrea Conti, Francesco Cusano, Paolo Dapavo, Clara DeSimone, May El Hachem, Gabriella Fabbrocini, Paolo Gisondi, Francesco Loconsole, Giuseppe Micali, Iria Neri, Aurora Parodi, Stefano Piaserico, Marco Romanelli, Luca Stingeni, Paolo D. M. Pigatto
Impact and Management of Loss of Eyebrows and Eyelashes
Michela Starace, Stephano Cedirian, Aurora M. Alessandrini, Francesca Bruni, Federico Quadrelli, Daniel F. Melo, Tatiana Silyuk, Andrei Doroshkevich, Bianca M. Piraccini, Matilde Iorizzo
Topical Isotretinoin (TMB-001) Treatment for 12 Weeks Did Not Result in Clinically Relevant Laboratory Abnormalities in Participants with Congenital Ichthyosis in the Phase 2b CONTROL Study
Kalyani Marathe, Joyce M. C. Teng, Scott Guenthner, Christopher G. Bunick, Steven Kempers, Kimmie Eads, Leslie Castelo-Soccio, Alan M. Mendelsohn, Jessica Raiz, Dédée F. Murrell
Photodynamic Therapy is an Effective Treatment of Facial Pigmented Actinic Keratosis
Ewelina Mazur, Adam Reich
Treatment of Stretch Marks Using a New Formulation Combining Nanofractional Radiofrequency Plus Magnetic Nanofractional Radiofrequency
Xiaohong Shu, Wei Huo, Lin Zou, Zhaoxia Li, Ying Tang, Li Li, Xi Wang
Suboptimal Clinical and Quality of Life Outcomes in Patients with Psoriasis Undertreated with Oral Therapies: International Physician and Patient Survey
Sydney Thai, Sophie Barlow, James Lucas, James Piercy, Yichen Zhong, Joe Zhuo, Jashin J. Wu
Biologic TNF-α Inhibitors for Stevens–Johnson Syndrome, Toxic Epidermal Necrolysis, and TEN-SJS Overlap: A Study-Level and Patient-Level Meta-Analysis
Jiali Cao, Xuan Zhang, Xinzhu Xing, Jie Fan
Patient and Physician Perceptions of Psoriatic Disease in the United States: Results from the UPLIFT Survey
Joseph F. Merola, Alexis Ogdie, Alice B. Gottlieb, Linda Stein Gold, Andrea Flower, Shauna Jardon, Yuri Klyachkin, Mark Lebwohl
Drug Survival of Tumor Necrosis Factor-Alpha Inhibitors and Switched Subsequent Biologic Agents in Patients with Psoriasis: A Retrospective Study
Megumi Kishimoto, Mayumi Komine, Koji Kamiya, Junichi Sugai, Aya Kuwahara, Makiko Mieno, Mamitaro Ohtsuki
The Needs of Patients with Psoriasis and Benefits of Apremilast in French Clinical Practice: Results from the Observational REALIZE Study
Denis Jullien, Marie-Aleth Richard, Bruno Halioua, Christel Bessette, Christian Derancourt, Anne Bouloc
InflammamiR-146a and -155 Plasma Levels are Associated with Clinical Efficacy of Risankizumab Treatment in Psoriatic Patients: Pilot Study
Federico Diotallevi, Giulia Matacchione, Giovanni Marco d’Agostino, Helena Gioacchini, Anna Campanati, Jacopo Sabbatinelli, Fabiola Olivieri, Annamaria Offidani
Publisher Correction: Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2)
Paolo Gisondi, Alice B. Gottlieb, Boni Elewski, Matthias Augustin, Sandy McBride, Tsen-Fang Tsai, Christine de la Loge, Frederik Fierens, José M. López Pinto, Nicola Tilt, Mark Lebwohl